CASSIE MILLER: Open Payments
NPI 1871877407 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,117 in 219 payments from 22 companies in 2025. Trend: 2023 $3,181 · 2024 $3,040 · 2025 $4,117
Food & beverage: $3,536Education: $581
| Company | Payments | Amount |
|---|---|---|
| OPKO Pharmaceuticals, LLC | 33 | $481 |
| Mallinckrodt Hospital Products Inc. | 23 | $463 |
| AstraZeneca Pharmaceuticals LP | 19 | $454 |
| Fresenius USA Marketing, Inc. | 18 | $340 |
| Amgen Inc. | 19 | $326 |
| Novartis Pharmaceuticals Corporation | 17 | $318 |
| Calliditas Therapeutics US Inc. | 16 | $292 |
| Travere Therapeutics, Inc. | 11 | $291 |
| Otsuka America Pharmaceutical, Inc. | 12 | $285 |
| Bayer Healthcare Pharmaceuticals Inc. | 18 | $228 |
Products named: RAYALDEE, ACTHAR, VELPHORO, TARPEYO, LOKELMA, Fabhalta, Kerendia, JYNARQUE.
Industry payments across LA — which companies pay providers there.
